First national report on aminotransaminases' percentiles in children of the middle East and North Africa (MENA): The CASPIAN-III study

Hepatitis Monthly

Volumn 12, Issue 11, 2012, Pages

  Kelishadi, Roya ^a   Abtahi, Seyed Hossein ^b   Qorbani, Mostafa ^c   Heshmat, Ramin ^d   Motlagh, Mohammad Esmaeil ^e,f   Taslimi, Mahnaz ^g   Aminaee, Tahereh ^f   Ardalan, Gelayol ^f   Poursafa, Parinaz ^a   Moin, Payam ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^g Ministry of Education and Training   (Iran)

Author keywords

Aminotransferase; Child; Iran

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGE; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; DISEASE ASSOCIATION; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; MIDDLE EAST; NORTH AFRICA; SCHOOL CHILD; WAIST CIRCUMFERENCE;

EID: 84867772028     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.7711     Document Type: Article

References (33)

1. Mencin AA, Lavine JE. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2011;14(2):151-7.
2. Kelishadi R, Poursafa P. Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. Hepat Mon. 2011;11(10):794-802.
3. Poggiogalle E, Olivero G, Anania C, Ferraro F, Pacifico L. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges]. Minerva Pediatr. 2010;62(6):569-84.
4. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology. 1998;27(5):1213-9.
5. Kelishadi R, Cook SR, Adibi A, Faghihimani Z, Ghatrehsamani S, Beihaghi A, et al. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normalweight, overweight and obese children and adolescents. Diabetol Metab Syndr. 2009;1:29.
6. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266-71.
7. Behrman R, Kliegman R, Jenson H. Nelson Textbook of Pediatrics. Amsterdam: Saunders; 2003.
8. Jamali R, Pourshams A, Amini S, Deyhim MR, Rezvan H, Malekzadeh R. The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med. 2008;11(6):602-7.
9. Di Bonito P, Sanguigno E, Di Fraia T, Forziato C, Boccia G, Saitta F, et al. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism. 2009;58(3):368-72.
10. Jagarinec N, Flegar-Mestric Z, Surina B, Vrhovski-Hebrang D, Preden-Kerekovic V. Pediatric reference intervals for 34 biochemical analytes in urban school children and adolescents. Clin Chem Lab Med. 1998;36(5):327-37.
11. Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA. Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc. 1990;65(3):329-36.
12. George J, Denney-Wilson E, Okely AD, Hardy LL, Aitken R. The population distributions, upper normal limits and correlations between liver tests among Australian adolescents. J Paediatr Child Health. 2008;44(10):579-85.
13. Lai DS, Chen SC, Chang YH, Chen CY, Lin JB, Lin YJ, et al. Pediatric reference intervals for several biochemical analytes in school children in Central Taiwan. J Formos Med Assoc. 2009;108(12):957-63.
14. Poustchi H, George J, Esmaili S, Esna-Ashari F, Ardalan G, Sepanlou SG, et al. Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One. 2011;6(6):e21178.
15. Volovelsky O, Weiss R. Fatty liver disease in obese children--relation to other metabolic risk factors. Int J Pediatr Obes. 2011;6 Suppl 1:59-64.
16. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol. 2011;17(26):3082-91.
17. Samani S, Kelishadi R, Adibi A. Association of serum alanine aminotransferase levels with cardiometabolic risk factors in normal- weight and overweight children. Iran J Pediatr. 2011;21(3):287-93.
18. Musaiger AO, Hassan AS, Obeid O. The paradox of nutrition-related diseases in the Arab countries: the need for action. Int J Environ Res Public Health. 2011;8(9):3637-71.
19. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev. 2007;29:62-76.
20. Schwandt P, Kelishadi R, Ribeiro RQ, Haas GM, Poursafa P. A threecountry study on the components of the metabolic syndrome in youths: the BIG Study. Int J Pediatr Obes. 2010;5(4):334-41.
21. Kelishadi R, Heshmat R, Motlagh ME, Majdzadeh R, Keramatian K, Qorbani M, et al. Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students' High Risk Behaviors. Int J Prev Med. 2012;3(6):394-401.
22. Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008;152(2):165-70.
23. England K, Thorne C, Pembrey L, Tovo PA, Newell ML. Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network. J Pediatr Gastroenterol Nutr. 2009;49(1):71-7.
24. Kariv R, Leshno M, Beth-Or A, Strul H, Blendis L, Kokia E, et al. Reevaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int. 2006;26(4):445-50.
25. Mohamadnejad M, Pourshams A, Malekzadeh R, Mohamadkhani A, Rajabiani A, Asgari AA, et al. Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroenterol. 2003;9(10):2322-4.
26. Hosseini M, Mousavi S, Poursafa P, Kelishadi R. Risk Score Model for Predicting Sonographic Non-alcoholic Fatty Liver Disease in Children and Adolescents. Iran J Pediatr. 2011;21(2):181-7.
27. Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc. 2010;69(2):211-20.
28. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38(10):954-61.
29. van Vliet M, von Rosenstiel IA, Schindhelm RK, Brandjes DP, Beijnen JH, Diamant M. The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin. Eur J Pediatr. 2009;168(5):585-91.
30. Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res Clin Pract. 2008;81(3):321-6.
31. Ciba I, Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr. 2007;96(1):109-12.
32. Quiros-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr. 2007;44(2):228-36.
33. Kangin M, Turhanoglu M, Gulsun S, Cakabay B. Seroprevalence of Hepatitis B and C among Children in Endemic Areas of Turkey. Hepat Mon. 2010;10(1):36-41.